Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

3062790 Title: COMBINAISONS PHARMACEUTIQUES POUR LE TRAITEMENT DU CANCER

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
148592207
WO application number:
AU2014001017
Type:
European patent granted for BE
Status:
Lapsed
Publication number:
3062790
WO publication number:
WO2015061832
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
31/10/2014
Grant date:
08/03/2023
EP publication date:
07/09/2016
WO publication date:
07/05/2015
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
08/03/2023
EP B1 publication date:
08/03/2023
EP B2 publication date:
EP B3 publication date:
Lapsed date:
31/10/2025
Expiration date (if granted and all annual fees paid):
31/10/2034

Applicant

Name:
Pitney Pharmaceuticals Pty Limited
Legal Form:
From:
08/03/2023
Address:
Suite 39 1 Freshwater Parade, Claremont, WA 6010, Australia (AU)
To:

Agent

Name:
KEMPES Wouter
Legal Form:
From:
20/03/2023
Address:
P.O. Box 2350, 1200 CJ, HILVERSUM, Netherlands (NL)
To:

Inventor

1

Name:
MORRIS, David Lawson
Legal Form:
Address:
Lugarno, NSW 2210, Australia (AU)

2

Name:
POURGHOLAMI, Mohammad Hossein
Legal Form:
Address:
Penshurst, NSW 2222, Australia (AU)

3

Name:
ASTON, Roger
Legal Form:
Address:
Docklands, VIC 3008, Australia (AU)

Priority

Priority patent number:
2013904239
Priority date:
01/11/2013
Priority country:
Australia (AU)

Classification

IPC or IDT classification:
A61K 31/277; A61K 31/65; A61K 31/704; A61K 31/513; A61K 31/337; A61K 31/7068; A61P 35/00;

Publication

Bulletin

Bulletin heading:
EP2
Journal edition number:
2023/05
Publication date:
29/03/2023
Description:
Contains data concerning European patents granted and published (B1 publication) for Belgium and for which no translation needed to be filed

European Patent Bulletin

Issue number:
202310
Publication date:
08/03/2023
Description:
Grant (B1)

Annual fee

Annual fee(s) Due Date:
Annual fee number:
Expected payer:
Last annual fee payment date:
17/09/2024
Last annual fee paid number:
11
Last annual fee paid amount:
215 Euro
Payer:
C.P.A.
Filing date Document type Publication Type Document Description Number of pages File Type
20/03/2023 Outgoing Correspondence 1 PDF /4/8/7/8/8/0722288784/docs/148592207_0_outgoingcorrespondence_20230321_084625434.pdf
20/03/2023 Incoming Correspondence (Email) Cover letter 1 PDF /4/8/7/8/8/0722288784/docs/148592207_1_incomingcorrespondenceelectronic_20230321_084625713.pdf
20/03/2023 General Document Other 1 PDF /4/8/7/8/8/0722288784/docs/148592207_2_generaldocument_20230321_084625547.pdf